Literature DB >> 4181749

Rifampicin.

J M Murdoch, C F Speirs, N Wright, E T Wallace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4181749     DOI： 10.1016/s0140-6736(69)91725-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Evidence that rifampicin can be used safely for non-tuberculous diseases.

Authors:  G Acocella; W Brumfitt; J M Hamilton-Miller
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

2.  Clinical uses and control of rifampicin and clindamycin.

Authors:  I Phillips
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

Review 3.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 4.  Use of rifampin in nonstaphylococcal, nonmycobacterial disease.

Authors:  A B Morris; R B Brown; M Sands
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.